HEADER IMMUNE SYSTEM 18-APR-24 9F13 TITLE CRYSTAL STRUCTURE OF HLA-C*12:02 IN COMPLEX WITH KAYNVTQAF (KF9), A 9- TITLE 2 MER EPITOPE FROM SARS-COV-2 NUCLEOCAPSID (N266-274) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN C ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HLA-C PROTEIN,MHC CLASS I ANTIGEN,MHC CLASS I PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 21-119; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: NUCLEOPROTEIN; COMPND 13 CHAIN: C; COMPND 14 SYNONYM: N,NUCLEOCAPSID PROTEIN,NC,PROTEIN N; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-C, HLA-CW; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 18 2; SOURCE 19 ORGANISM_TAXID: 2697049 KEYWDS HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-C12, KEYWDS 2 HLA-C*12:02, SARS-COV-2, NUCLEOCAPSID, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.M.AHN,J.C.MADDUMAGE,D.S.M.CHATZILEONTIADOU,S.GRAS REVDAT 2 10-SEP-25 9F13 1 JRNL REVDAT 1 06-AUG-25 9F13 0 JRNL AUTH Y.GOTO,Y.M.AHN,M.TOYODA,H.HAMANA,Y.JIN,Y.ARITSU,T.NAKAMA, JRNL AUTH 2 Y.TAJIMA,J.C.MADDUMAGE,H.LI,M.KITAMATSU,H.KISHI,A.YONEKAWA, JRNL AUTH 3 D.JAYASINGHE,N.SHIMONO,Y.NAGASAKI,R.MINAMI,T.TOYA,N.SEKIYA, JRNL AUTH 4 Y.TOMITA,D.S.M.CHATZILEONTIADOU,H.NAKATA,S.NAKAGAWA, JRNL AUTH 5 T.SAKAGAMI,T.UENO,S.GRAS,C.MOTOZONO JRNL TITL MOLECULAR BASIS OF POTENT ANTIVIRAL HLA-C-RESTRICTED CD8 + T JRNL TITL 2 CELL RESPONSE TO AN IMMUNODOMINANT SARS-COV-2 NUCLEOCAPSID JRNL TITL 3 EPITOPE. JRNL REF NAT COMMUN V. 16 8062 2025 JRNL REFN ESSN 2041-1723 JRNL PMID 40877317 JRNL DOI 10.1038/S41467-025-63288-3 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX REMARK 1 REF ACTA CRYSTALLOGR., SECT. D: V. 75 861 2019 REMARK 1 REF 2 BIOL. CRYSTALLOGR. REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 1.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.21RC1_5127 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 49891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 2588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.2700 - 4.2200 1.00 2699 144 0.1576 0.1869 REMARK 3 2 4.2200 - 3.3500 1.00 2641 150 0.1854 0.2011 REMARK 3 3 3.3500 - 2.9300 1.00 2631 139 0.2087 0.2551 REMARK 3 4 2.9300 - 2.6600 1.00 2646 141 0.2247 0.2194 REMARK 3 5 2.6600 - 2.4700 1.00 2625 160 0.2175 0.2406 REMARK 3 6 2.4700 - 2.3200 1.00 2621 148 0.2246 0.2127 REMARK 3 7 2.3200 - 2.2100 1.00 2626 142 0.2188 0.2639 REMARK 3 8 2.2100 - 2.1100 1.00 2617 142 0.2128 0.2365 REMARK 3 9 2.1100 - 2.0300 1.00 2618 148 0.2233 0.2729 REMARK 3 10 2.0300 - 1.9600 1.00 2634 139 0.2231 0.2769 REMARK 3 11 1.9600 - 1.9000 1.00 2589 155 0.2209 0.2667 REMARK 3 12 1.9000 - 1.8400 1.00 2632 140 0.2357 0.2701 REMARK 3 13 1.8400 - 1.7900 1.00 2614 135 0.2307 0.2840 REMARK 3 14 1.7900 - 1.7500 1.00 2641 142 0.2173 0.2613 REMARK 3 15 1.7500 - 1.7100 1.00 2621 150 0.2189 0.2422 REMARK 3 16 1.7100 - 1.6700 1.00 2626 132 0.2282 0.2425 REMARK 3 17 1.6700 - 1.6400 1.00 2590 142 0.2209 0.3028 REMARK 3 18 1.6400 - 1.6100 1.00 2632 139 0.2404 0.2666 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.187 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.919 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3315 REMARK 3 ANGLE : 0.653 4513 REMARK 3 CHIRALITY : 0.047 456 REMARK 3 PLANARITY : 0.006 599 REMARK 3 DIHEDRAL : 14.308 1247 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9F13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-APR-24. REMARK 100 THE DEPOSITION ID IS D_1292137949. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-FEB-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953732 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49905 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.610 REMARK 200 RESOLUTION RANGE LOW (A) : 47.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.48900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2% PEG400, 20% PEG3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 23.69153 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.56150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.89812 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 23.69153 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 38.56150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 40.89812 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -23 REMARK 465 ARG A -22 REMARK 465 VAL A -21 REMARK 465 MET A -20 REMARK 465 ALA A -19 REMARK 465 PRO A -18 REMARK 465 ARG A -17 REMARK 465 THR A -16 REMARK 465 LEU A -15 REMARK 465 ILE A -14 REMARK 465 LEU A -13 REMARK 465 LEU A -12 REMARK 465 LEU A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 ALA A -8 REMARK 465 LEU A -7 REMARK 465 ALA A -6 REMARK 465 LEU A -5 REMARK 465 THR A -4 REMARK 465 GLU A -3 REMARK 465 THR A -2 REMARK 465 TRP A -1 REMARK 465 ALA A 0 REMARK 465 SER A 277 REMARK 465 SER A 278 REMARK 465 GLN A 279 REMARK 465 PRO A 280 REMARK 465 THR A 281 REMARK 465 ILE A 282 REMARK 465 PRO A 283 REMARK 465 ILE A 284 REMARK 465 VAL A 285 REMARK 465 GLY A 286 REMARK 465 ILE A 287 REMARK 465 VAL A 288 REMARK 465 ALA A 289 REMARK 465 GLY A 290 REMARK 465 LEU A 291 REMARK 465 ALA A 292 REMARK 465 VAL A 293 REMARK 465 LEU A 294 REMARK 465 ALA A 295 REMARK 465 VAL A 296 REMARK 465 LEU A 297 REMARK 465 ALA A 298 REMARK 465 VAL A 299 REMARK 465 LEU A 300 REMARK 465 GLY A 301 REMARK 465 ALA A 302 REMARK 465 VAL A 303 REMARK 465 MET A 304 REMARK 465 ALA A 305 REMARK 465 VAL A 306 REMARK 465 VAL A 307 REMARK 465 MET A 308 REMARK 465 CYS A 309 REMARK 465 ARG A 310 REMARK 465 ARG A 311 REMARK 465 LYS A 312 REMARK 465 SER A 313 REMARK 465 SER A 314 REMARK 465 GLY A 315 REMARK 465 GLY A 316 REMARK 465 LYS A 317 REMARK 465 GLY A 318 REMARK 465 GLY A 319 REMARK 465 SER A 320 REMARK 465 CYS A 321 REMARK 465 SER A 322 REMARK 465 GLN A 323 REMARK 465 ALA A 324 REMARK 465 ALA A 325 REMARK 465 SER A 326 REMARK 465 SER A 327 REMARK 465 ASN A 328 REMARK 465 SER A 329 REMARK 465 ALA A 330 REMARK 465 GLN A 331 REMARK 465 GLY A 332 REMARK 465 SER A 333 REMARK 465 ASP A 334 REMARK 465 GLU A 335 REMARK 465 SER A 336 REMARK 465 LEU A 337 REMARK 465 ILE A 338 REMARK 465 ALA A 339 REMARK 465 CYS A 340 REMARK 465 LYS A 341 REMARK 465 ALA A 342 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 1 CB SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 14 71.64 -152.65 REMARK 500 ASP A 29 -125.28 53.10 REMARK 500 ASP A 114 86.83 -161.95 REMARK 500 TRP B 60 -4.79 80.06 REMARK 500 VAL C 5 115.05 62.45 REMARK 500 REMARK 500 REMARK: NULL DBREF 9F13 A -23 342 UNP Q546I6 Q546I6_HUMAN 1 366 DBREF 9F13 B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 9F13 C 1 9 UNP P0DTC9 NCAP_SARS2 266 274 SEQADV 9F13 MET B 0 UNP P61769 INITIATING METHIONINE SEQRES 1 A 366 MET ARG VAL MET ALA PRO ARG THR LEU ILE LEU LEU LEU SEQRES 2 A 366 SER GLY ALA LEU ALA LEU THR GLU THR TRP ALA CYS SER SEQRES 3 A 366 HIS SER MET ARG TYR PHE TYR THR ALA VAL SER ARG PRO SEQRES 4 A 366 GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY TYR VAL SEQRES 5 A 366 ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP ALA ALA SEQRES 6 A 366 SER PRO ARG GLY GLU PRO ARG ALA PRO TRP VAL GLU GLN SEQRES 7 A 366 GLU GLY PRO GLU TYR TRP ASP ARG GLU THR GLN LYS TYR SEQRES 8 A 366 LYS ARG GLN ALA GLN ALA ASP ARG VAL SER LEU ARG ASN SEQRES 9 A 366 LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SER HIS SEQRES 10 A 366 THR LEU GLN ARG MET TYR GLY CYS ASP LEU GLY PRO ASP SEQRES 11 A 366 GLY ARG LEU LEU ARG GLY TYR ASP GLN SER ALA TYR ASP SEQRES 12 A 366 GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU ARG SER SEQRES 13 A 366 TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR GLN ARG SEQRES 14 A 366 LYS TRP GLU ALA ALA ARG GLU ALA GLU GLN TRP ARG ALA SEQRES 15 A 366 TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG ARG TYR SEQRES 16 A 366 LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA GLU HIS SEQRES 17 A 366 PRO LYS THR HIS VAL THR HIS HIS PRO VAL SER ASP HIS SEQRES 18 A 366 GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE TYR PRO SEQRES 19 A 366 ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY GLU ASP SEQRES 20 A 366 GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG PRO ALA SEQRES 21 A 366 GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL VAL VAL SEQRES 22 A 366 PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS VAL GLN SEQRES 23 A 366 HIS GLU GLY LEU PRO GLU PRO LEU THR LEU ARG TRP GLU SEQRES 24 A 366 PRO SER SER GLN PRO THR ILE PRO ILE VAL GLY ILE VAL SEQRES 25 A 366 ALA GLY LEU ALA VAL LEU ALA VAL LEU ALA VAL LEU GLY SEQRES 26 A 366 ALA VAL MET ALA VAL VAL MET CYS ARG ARG LYS SER SER SEQRES 27 A 366 GLY GLY LYS GLY GLY SER CYS SER GLN ALA ALA SER SER SEQRES 28 A 366 ASN SER ALA GLN GLY SER ASP GLU SER LEU ILE ALA CYS SEQRES 29 A 366 LYS ALA SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 LYS ALA TYR ASN VAL THR GLN ALA PHE FORMUL 4 HOH *208(H2 O) HELIX 1 AA1 ALA A 49 GLU A 53 5 5 HELIX 2 AA2 GLY A 56 TYR A 85 1 30 HELIX 3 AA3 ASP A 137 ALA A 150 1 14 HELIX 4 AA4 ARG A 151 GLY A 162 1 12 HELIX 5 AA5 GLY A 162 GLY A 175 1 14 HELIX 6 AA6 GLY A 175 GLN A 180 1 6 HELIX 7 AA7 GLU A 253 GLN A 255 5 3 SHEET 1 AA1 8 GLU A 46 PRO A 47 0 SHEET 2 AA1 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 AA1 8 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 4 AA1 8 HIS A 3 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 AA1 8 THR A 94 LEU A 103 -1 O LEU A 103 N HIS A 3 SHEET 6 AA1 8 LEU A 109 TYR A 118 -1 O ARG A 111 N ASP A 102 SHEET 7 AA1 8 LYS A 121 LEU A 126 -1 O ILE A 124 N SER A 116 SHEET 8 AA1 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 LYS A 186 PRO A 193 0 SHEET 2 AA2 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA2 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA2 4 THR A 228 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 AA3 4 LYS A 186 PRO A 193 0 SHEET 2 AA3 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA3 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA3 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA4 4 GLU A 222 GLN A 224 0 SHEET 2 AA4 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 AA4 4 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 4 AA4 4 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261 SHEET 1 AA5 4 LYS B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA5 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AA6 4 LYS B 6 SER B 11 0 SHEET 2 AA6 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA6 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA6 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA7 4 GLU B 44 ARG B 45 0 SHEET 2 AA7 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AA7 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 AA7 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.02 CISPEP 1 TYR A 209 PRO A 210 0 1.10 CISPEP 2 HIS B 31 PRO B 32 0 2.63 CRYST1 62.102 77.123 83.110 90.00 100.20 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016103 0.000000 0.002898 0.00000 SCALE2 0.000000 0.012966 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012226 0.00000 CONECT 861 1367 CONECT 1367 861 CONECT 1696 2152 CONECT 2152 1696 CONECT 2516 2979 CONECT 2979 2516 MASTER 352 0 0 7 32 0 0 6 3375 3 6 38 END